1
Enquiry period
with 17.07.2023 17:26
to 27.07.2023 14:00
2
Bidding period
with 27.07.2023 14:00
to 02.08.2023 14:00
3
Auction
with 03.08.2023 15:00
to 03.08.2023 15:28
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 976 884,63 MDL
Period of clarifications: 17 Jul 2023, 17:26 - 27 Jul 2023, 14:00
Submission of proposals: 27 Jul 2023, 14:00 - 2 Aug 2023, 14:00

Supplier technical support:

(+373) 79999801

“Achiziţionarea medicamentelor pentru realizarea Programului Naţional de prevenire și control HIV/SIDA și ITS pentru anul 2023 suplimentar 1”

Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
17 Jul 2023, 17:13
Date modified
17 Jul 2023, 17:26
Achizitii.md ID
21085158
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
Documents of the procurement procedure
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
17.07.23 17:26
contract model PN
Draft contract - special conditions
contract model PN
17.07.23 17:26
Documentatia standard.signed
Bidding Documents
Documentatia standard.signed
17.07.23 17:26
Propunerea financiară
Technical Specifications
Propunerea financiară
17.07.23 17:26
Propunerea tehnică
Technical Specifications
Propunerea tehnică
17.07.23 17:26
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
17.07.23 17:26
DUAE Model
Bidding Documents
DUAE Model
17.07.23 17:26
Anunt de participare din 17.07.2023.signed
Bidding Documents
Anunt de participare din 17.07.2023.signed
17.07.23 17:26
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
17.07.23 17:26
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
17.07.23 17:26
Only authorized platform users may ask questions during the clarification period.